Fig. 8

Differences in clinical characteristics and somatic mutations between high- and low-risk groups. A, B The differences in the proportion of conventional clinicopathological factors between high- and low-risk groups and the differences in risk scores between different clinicopathological factors were compared. C, D The difference in the proportion of somatic mutation positive and negative patients between high- and low-risk groups and the difference in risk scores between somatic mutation positive and negative patients. E Differences in overall somatic mutation frequency between high- and low-risk groups. FAB: French–American–British; WBC: white blood cell